M J Schwarz

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. ncbi COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date
    Michael Riedel
    Department of Psychiatry and Psychotherapy, Ludwig Maximilan University of Munich, Munich, Germany
    CNS Drugs 19:805-19. 2005
  2. ncbi Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients
    M J Schwarz
    Psychiatric Hospital, University of Munich, Germany
    Neurosci Lett 259:196-8. 1999
  3. ncbi Experimental evaluation of an altered tryptophan metabolism in fibromyalgia
    Markus J Schwarz
    Psychiatric Hospital, University of Munich, Nussbaumstr 7, D 80336 Munich, Germany
    Adv Exp Med Biol 527:265-75. 2003
  4. ncbi Antibodies to heat shock proteins in schizophrenic patients: implications for the mechanism of the disease
    M J Schwarz
    Psychiatric Hospital, Department of Neurochemistry, Psychiatric Hospital, Ludwig Maximilian University Munich, Germany
    Am J Psychiatry 156:1103-4. 1999
  5. ncbi The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms
    M J Schwarz
    Psychiatric Hospital, University of Munich, Munich, Germany
    Med Hypotheses 56:483-6. 2001
  6. ncbi Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia
    M J Schwarz
    Department of Neurochemistry, University of Munich, Germany
    Neurosci Lett 253:201-3. 1998
  7. ncbi Melanoma-associated adhesion molecule MUC18/MCAM (CD146) and transcriptional regulator mader in normal human CNS
    M J Schwarz
    Department of Neurochemistry, Psychiatric Hospital, University of Munich, Germany
    Neuroimmunomodulation 5:270-6. 1998
  8. ncbi CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis
    F Padberg
    Department of Psychiatry, Ludwig Maximilian University, Munich, Germany
    J Neuroimmunol 99:218-23. 1999
  9. ncbi Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130
    S Stubner
    Department of Psychiatry, Ludwig Maximillian University, Munich, Germany
    Neurosci Lett 259:145-8. 1999
  10. ncbi Evidence for an altered tryptophan metabolism in fibromyalgia
    M J Schwarz
    Psychiatric Hospital, University of Munich, D 80336, Munich, Germany
    Neurobiol Dis 11:434-42. 2002

Detail Information

Publications54

  1. ncbi COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date
    Michael Riedel
    Department of Psychiatry and Psychotherapy, Ludwig Maximilan University of Munich, Munich, Germany
    CNS Drugs 19:805-19. 2005
    ..While the first trial using celecoxib as add-on therapy to an atypical antipsychotic showed a significant beneficial effect, recent studies demonstrated that this effect may be limited to patients with recent-onset schizophrenia...
  2. ncbi Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients
    M J Schwarz
    Psychiatric Hospital, University of Munich, Germany
    Neurosci Lett 259:196-8. 1999
    ..Moreover, 5-HIAA was strongly related to good quality of sleep (P = .000), while SP was related to sleep disturbance (P = .005). These data are valid to support the hypothesis of a systemic involvement of 5-HT and SP in fibromyalgia...
  3. ncbi Experimental evaluation of an altered tryptophan metabolism in fibromyalgia
    Markus J Schwarz
    Psychiatric Hospital, University of Munich, Nussbaumstr 7, D 80336 Munich, Germany
    Adv Exp Med Biol 527:265-75. 2003
    ..Our findings may have diagnostic as well as therapeutic implications in the field of fibromyalgia...
  4. ncbi Antibodies to heat shock proteins in schizophrenic patients: implications for the mechanism of the disease
    M J Schwarz
    Psychiatric Hospital, Department of Neurochemistry, Psychiatric Hospital, Ludwig Maximilian University Munich, Germany
    Am J Psychiatry 156:1103-4. 1999
    ..To elucidate their role in schizophrenia, the authors investigated antibody titers to heat shock proteins in unmedicated and medicated patients with schizophrenia...
  5. ncbi The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms
    M J Schwarz
    Psychiatric Hospital, University of Munich, Munich, Germany
    Med Hypotheses 56:483-6. 2001
    ..Besides the immunological abnormalities, this subgroup is further characterized by more pronounced negative symptoms and poor therapy outcome. There is evidence that this subgroup might be caused by a prenatal viral infection...
  6. ncbi Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia
    M J Schwarz
    Department of Neurochemistry, University of Munich, Germany
    Neurosci Lett 253:201-3. 1998
    ..A BCB impairment was associated with high levels of sICAM-1. Our data indicate an inflammatory mechanism of BCB impairment in schizophrenics and should enrich the discussion on an expanded immunological diagnosis in schizophrenia...
  7. ncbi Melanoma-associated adhesion molecule MUC18/MCAM (CD146) and transcriptional regulator mader in normal human CNS
    M J Schwarz
    Department of Neurochemistry, Psychiatric Hospital, University of Munich, Germany
    Neuroimmunomodulation 5:270-6. 1998
    ..These observations may have important implications for further studies investigating their possible roles in cell adhesion and proliferation control within the CNS...
  8. ncbi CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis
    F Padberg
    Department of Psychiatry, Ludwig Maximilian University, Munich, Germany
    J Neuroimmunol 99:218-23. 1999
    ..Furthermore, sgp130 CSF levels were decreased in MS, suggesting a possibly altered IL-6 regulation in the CSF...
  9. ncbi Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130
    S Stubner
    Department of Psychiatry, Ludwig Maximillian University, Munich, Germany
    Neurosci Lett 259:145-8. 1999
    ..We found statistically significant decreased CSF concentrations of IL-6 (P<0.001) and of the sIL-6R (P<0.001) of patients with MD. Levels of sgp130 showed no statistically significant difference between patients and controls...
  10. ncbi Evidence for an altered tryptophan metabolism in fibromyalgia
    M J Schwarz
    Psychiatric Hospital, University of Munich, D 80336, Munich, Germany
    Neurobiol Dis 11:434-42. 2002
    ..These data demonstrate an altered TRP metabolism in a subgroup of FM patients, where the TD seems to activate 5-HT metabolism. Our findings may have diagnostic as well as therapeutic implications in the field of fibromyalgia...
  11. ncbi Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease
    H Hampel
    Department of Psychiatry, Geriatric Psychiatry Branch, Dementia Research Section, Ludwig Maximilian University Munich, Nussbaumstr 7, 80336, Munich, Germany
    Brain Res 823:104-12. 1999
    ....
  12. ncbi Detection of the novel cell adhesion molecule MUC18 in human brain tissue
    H Hampel
    Department of Psychiatry, Ludwig Maximilian University, Munich, Germany
    Neuroimmunomodulation 4:57-61. 1997
    ....
  13. ncbi Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease
    H Hampel
    Department of Psychiatry, Ludwig Maximilian University, School of Medicine, Munich, Germany
    Neurosci Lett 228:143-6. 1997
    ..We suggest that combined measurement of all parameters of the IL-6-receptor complex could yield more insight in a probably altered IL-6 function...
  14. ncbi Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation
    N Muller
    Department of Psychiatry, Ludwig Maximilians University, Nussbaumstr 7, 80336 Munich, Germany
    World J Biol Psychiatry 1:173-9. 2000
    ..During therapy with antipsychotics, the specific TH-1 related immune answer becomes activated, but the B-cell system and the antibody production become activated too...
  15. ncbi The immune system and schizophrenia. An integrative view
    N Muller
    Psychiatric Hospital, Ludwig Maximilian University, Munich, Germany
    Ann N Y Acad Sci 917:456-67. 2000
    ..During antipsychotic therapy with neuroleptics, the specific TH-1-related immune answer becomes activated, but in addition the B cell system and antibody production increase...
  16. ncbi Increase in expression of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood-brain barrier permeability in schizophrenia
    N Muller
    Psychiatric Hospital, Ludwig Maximillian University, Munich, Germany
    Am J Psychiatry 156:634-6. 1999
    ....
  17. ncbi Cerebrospinal fluid tau protein shows a better discrimination in young old (<70 years) than in old old patients with Alzheimer's disease compared with controls
    K Bürger née Buch
    Department of Psychiatry, Geriatric Psychiatry Branch, Dementia Research Section and Memory Clinic, Ludwig Maximilian University, Munich, Germany
    Neurosci Lett 277:21-4. 1999
    ..We suggest that the effect of age should be considered in studies investigating CSF tau as a diagnostic marker for neurodegenerative disorders...
  18. ncbi Autoantibodies against 60-kDa heat shock protein in schizophrenia
    M J Schwarz
    , Munich, Germany
    Eur Arch Psychiatry Clin Neurosci 248:282-8. 1998
    ..Whether or not this differential response to treatment with altered antibody production represents a subgroup of patients has yet to be determined...
  19. ncbi Risperidone plasma levels, clinical response and side-effects
    Michael Riedel
    Dept of Psychiatry and Psychotherapy, University of Munich, 80336 Munich, Germany
    Eur Arch Psychiatry Clin Neurosci 255:261-8. 2005
    ..We thus prospectively investigated risperidone serum concentrations in relation to clinical efficacy and side-effects and genotyped major CYP2D6 polymorphisms to determine their effect upon these parameters...
  20. ncbi Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndrome
    N Muller
    Psychiatric Hospital, Ludwig Maximilian University, Nussbaumstr 7, D 80336, Munchen, Germany
    Psychiatry Res 101:187-93. 2001
    ..The finding of a possible autoimmune origin of TS has implications for both pathophysiology and future therapeutic strategies...
  21. doi Effects of experimentally induced panic attacks on neuroimmunological markers
    L de la Fontaine
    Department of Psychiatry, Ludwig Maximilian University, Nussbaumstr 7, 80336 Munich, Germany
    J Neural Transm 116:699-702. 2009
    ..Herein we conducted for the first time a new approach to immunological research in panic disorder, suggesting immune changes are more related to long term disease stress...
  22. ncbi No association between anti-myelin oligodendrocyte glycoprotein antibodies and serum/cerebrospinal fluid levels of the soluble interleukin-6 receptor complex in multiple sclerosis
    F Padberg
    Department of Psychiatry, Ludwig Maximilian University, Nussbaumstrasse 7, 80336, Munich, Germany
    Neurosci Lett 305:13-6. 2001
    ..There was no difference in IL-6 and sIL-6RC levels between anti-MOG abs positive and negative samples. Thus, no association between the presence of anti-MOG abs and serum/CSF levels of IL-6/sIL-6RC was found...
  23. ncbi Psychotropic effects of COX-2 inhibitors--a possible new approach for the treatment of psychiatric disorders
    N Muller
    Hospital for Psychiatry and Psychotherapy, Ludwig Maximilians Universitat, Nussbaumstrasse 7, 80336 Munich, Germany
    Pharmacopsychiatry 37:266-9. 2004
    ..These preliminary clinical data are encouraging for therapeutic effects of the selective COX-2 inhibitors in psychiatric disorders, although these effects have to be confirmed in bigger clinical studies...
  24. ncbi The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
    N Muller
    Hospital for Psychiatry and Psychotherapy, Ludwig Maximilians Universitat, Munchen, Germany
    Mol Psychiatry 11:680-4. 2006
    ..Moreover, the fact that treatment with an anti-inflammatory drug showed beneficial effects on MD indicates that inflammation is related to the pathomechanism of the disorder, although the exact mechanisms remain to become elucidated...
  25. ncbi [Immunological aspects of depressive disorders]
    N Muller
    Klinik fur Psychiatrie und Psychotherapie, Ludwig Maximilians Universitat, Nussbaumstrasse 7, 80336 Munchen
    Nervenarzt 78:1261-73. 2007
    ..The further search for new antidepressant therapeutic mechanisms should take into regard anti-inflammatory substances, e.g. cyclo-oxygenase-2 (COX-2)-inhibitors...
  26. ncbi [Immunology in schizophrenic disorders]
    N Muller
    Klinik fur Psychiatrie und Psychotherapie, Ludwig Maximilians Universitat, Nussbaumstrasse 7, 80336 Munchen
    Nervenarzt 78:253-6, 258-60, 262-3. 2007
    ..This model describes the pathway of immune-mediated glutamatergic-dopaminergic dysregulation, which may lead to the clinical symptoms of schizophrenia. Therapeutic consequences (e.g. cyclo-oxygenase-2 inhibitors) are discussed...
  27. ncbi The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
    N Muller
    Department for Psychiatry and Psychotherapy, Ludwig Maximilians Universitat Munchen, Munchen, Germany
    Mol Psychiatry 12:988-1000. 2007
    ....
  28. ncbi The role of immune function in schizophrenia: an overview
    N Muller
    Psychiatrische Klinik, Ludwig Maximilians Universitat, Munchen
    Eur Arch Psychiatry Clin Neurosci 249:62-8. 1999
    ..During antipsychotic therapy with neuroleptics, the specific TH-1 related immune answer becomes activated, but also the B-cell system and the antibody production increases...
  29. ncbi T-helper-1 and T-helper-2 responses in psychiatric disorders
    M J Schwarz
    Psychiatric Hospital, University of Munich, Nussbaumstr. 7, D-80336 Munich, Germany
    Brain Behav Immun 15:340-70. 2001
    ..Categorization of immune parameters may also help to identify a possible immune-related pathophysiology in psychotic and affective disorders, resulting in specific treatment strategies...
  30. ncbi Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression
    C Minov
    Department of Psychiatry, Ludwig Maximilians University of Munich, Nussbaumstrasse 7, D 80336, Munich, Germany
    Neurosci Lett 303:119-22. 2001
    ..However, subtypes might be identified at least on a basis of differential treatment response...
  31. ncbi Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results
    S Dittmann
    Department of Psychiatry, Ludwigs Maximilians University, Munich, Germany
    Bipolar Disord 9:63-70. 2007
    ..However, the pathophysiological mechanisms of these deficits have not been elucidated yet. This study examines the role of Hcy on cognition and its impact on psychosocial functioning in euthymic bipolar patients...
  32. ncbi Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders
    Norbert Muller
    Ludwig Maximilians Universitat Munchen, Hospital for Psychiatry and Psychotherapy, 80336 Munchen, Germany
    Expert Rev Neurother 6:1017-38. 2006
    ..The limitations of this concept, however, are critically discussed...
  33. ncbi Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia
    Norbert Muller
    Psychiatric and Psychotherapeutic Hospital, Ludwig Maximilians University, Munich, Germany
    Am J Psychiatry 159:1029-34. 2002
    ..The authors conducted a trial of the new selective cyclooxygenase-2 inhibitor celecoxib, an immunomodulatory drug, in schizophrenic patients to evaluate its therapeutic effects...
  34. ncbi Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma
    Astrid Friebe
    Department of Psychiatry, Charite, Campus Mitte, Berlin, Germany
    J Immunother 30:333-7. 2007
    ..In contrast to the initial hypothesis, patients characterized by high sTNF-R1 and low sIL-6R baseline levels, indicating an anti-inflammatory condition before therapy, had a higher vulnerability for depression during IFN-alpha therapy...
  35. ncbi COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy
    Norbert Muller
    Hospital for Psychiatry and Psychotherapy, Ludwig Maximilians Universitat, Nussbaumstrasse 7, 80336 Munich, Germany
    Eur Arch Psychiatry Clin Neurosci 254:14-22. 2004
    ....
  36. ncbi Alexithymia and interleukin variations in somatoform disorder
    Francisco Pedrosa Gil
    Psychosomatic Ambulance and Outpatient Clinic, Department of Internal Medicine Innenstadt, Ludwig Maximilians University, Munich, Germany
    Neuroimmunomodulation 14:235-42. 2007
    ....
  37. ncbi The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study
    Sandra Dittmann
    Department of Psychiatry and Psychotherapy, Ludwig Maximilians University, Munich, Germany
    J Clin Psychiatry 69:899-906. 2008
    ..High homocysteine levels seem to have a negative impact on cognition in the elderly. The aim of the present study was to investigate the potential relationship of elevated homocysteine levels and cognitive impairment in bipolar patients...
  38. doi A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders
    Norbert Muller
    Hospital for Psychiatry and Psychotherapy, Ludwig Maximilians Universitat, Nubbaumstr 7, 80336, Munich, Germany
    Eur Arch Psychiatry Clin Neurosci 258:97-106. 2008
    ....
  39. ncbi COX-2 inhibition in schizophrenia and major depression
    Norbert Muller
    Department of Psychiatry and Psychotherapy, Ludwig Maximilians Universitat Munchen, Germany
    Curr Pharm Des 14:1452-65. 2008
    ....
  40. ncbi Decreased T cellular immune response in schizophrenic patients
    Michael Riedel
    Department of Psychiatry and Psychotherapy, Ludwig Maximilians University of Munich, Nussbaumstrasse 7, D 80336 Munich, Germany
    J Psychiatr Res 41:3-7. 2007
    ..Our findings demonstrate a markedly attenuated in vivo type-1 mediated cellular immune response in schizophrenic patients, further confirming the hypothesis of a relative Th2 shift in schizophrenia...
  41. ncbi Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms
    Michael Riedel
    Ludwig Maximilians University of Munich, Dept of Psychiatry and Psychotherapy, Nussbaumstrasse 7, 80336, Munich, Germany
    Eur Arch Psychiatry Clin Neurosci 255:432-7. 2005
    ..Quetiapine is also well tolerated, with a lower incidence of EPS and prolactin increase than risperidone...
  42. ncbi Substance P serum levels are increased in major depression: preliminary results
    Brigitta Bondy
    Psychiatric Hospital, University of Munich, Germany
    Biol Psychiatry 53:538-42. 2003
    ..The aim of this study was to analyze the serum SP levels in healthy control subjects and in depressed patients before and after antidepressant treatments...
  43. ncbi Effects of tryptophan depletion and catecholamine depletion on immune parameters in patients with seasonal affective disorder in remission with light therapy
    Jürgen Stastny
    Department of General Psychiatry, University of Vienna, Vienna, Austria
    Biol Psychiatry 53:332-7. 2003
    ....
  44. ncbi COX-2 inhibitors as adjunctive therapy in schizophrenia
    Norbert Muller
    Ludwig Maximilans University, Department of Psychiatry and Psychotherapy, Nussbaumstrasse 7, D 80336 Munich, Germany
    Expert Opin Investig Drugs 13:1033-44. 2004
    ..These preliminary clinical data are encouraging for clinical therapeutic effects of the selective COX-2 inhibitors in psychiatric disorders, although these effects have to be confirmed in larger clinical studies...
  45. ncbi Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alpha
    Martin Schaefer
    Department of Psychiatry, Charite University Medicine Berlin, Campus Charite Mitte, Schumannstr 20 21, D 10117 Berlin, Germany
    Brain Behav Immun 18:555-62. 2004
    ..367, p = .018). Our data provides evidence for an association between the induction of sICAM-1 and the development of symptoms of depression during IFN-alpha treatment, possibly by enhancing BBB-permeability...
  46. ncbi Clinical effects of COX-2 inhibitors on cognition in schizophrenia
    Norbert Muller
    Hospital for Psychiatry and Psychotherapy, Ludwig Maximilians Universitat, Nussbaumstr 7, 80336 Munchen, Germany
    Eur Arch Psychiatry Clin Neurosci 255:149-51. 2005
    ..In schizophrenia, the effect on cognition contributes to the therapeutic effect of COX-2 inhibitors...
  47. ncbi Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression
    Alexander Neumeister
    National Institutes of Health, NIMH, Mood and Anxiety Disorders Program, Bethesda, MD 20892 2670
    Arch Gen Psychiatry 59:613-20. 2002
    ..We studied the behavioral responses to tryptophan depletion (TD) in healthy women with and without a first-degree family history of depression and examined the relationship to 5HTTLPR alleles...
  48. ncbi No association between the G308A polymorphism of the tumor necrosis factor-alpha gene and schizophrenia
    Michael Riedel
    Psychiatric Hospital, Ludwig Maximilian University Munich, Nussbaumstr 7, 80336 Munich, Germany
    Eur Arch Psychiatry Clin Neurosci 252:232-4. 2002
    ..9 % polymorphic allele). Moreover, we did not find any association between genotype and psychopathology, as measured by PANSS. The different results between these two studies may be due to ethnic differences...
  49. ncbi ICAM G241A polymorphism and soluble ICAM-1 serum levels: evidence for an active immune process in schizophrenia
    Holger Kronig
    Psychiatric Hospital, Ludwig Maximilian University Munich, Munich, Germany
    Neuroimmunomodulation 12:54-9. 2005
    ..The G-->A SNP results in a nonsynonymous amino acid exchange of the ICAM-1 protein, and the A allele was shown to be also associated with several immunological disorders like rheumatoid arthritis...
  50. ncbi Cytomegalovirus and schizophrenia
    E Fuller Torrey
    The Stanley Medical Research Institute and Uniformed Services University of the Health Sciences, Bethesda, MD 20814 2142, USA
    CNS Drugs 20:879-85. 2006
    ..Further studies on CMV and schizophrenia are needed and may lead to improved treatments for schizophrenia...
  51. ncbi Investigating disease susceptibility and the negative correlation of schizophrenia and rheumatoid arthritis focusing on MIF and CD14 gene polymorphisms
    Larissa de la Fontaine
    Klinik fur Psychiatrie und Psychotherapie, Nussbaumstr 7, Ludwig Maximilians Universitat, D 80336 MUnchen, Germany
    Psychiatry Res 144:39-47. 2006
    ....
  52. ncbi Effects of tryptophan depletion on the serotonin transporter in healthy humans
    Nicole Praschak-Rieder
    Vivian M Rakoff PET Imaging Centre, Centre for Addiction and Mental Health, and Department of Psychiatry, University of Toronto, Toronto, Canada
    Biol Psychiatry 58:825-30. 2005
    ..Adaptive decreases in 5-HTT density and/or affinity during TD would be a possible compensatory mechanism to maintain sufficient extracellular serotonin levels during TD, thereby preventing a depressive relapse...
  53. ncbi IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia
    Markus J Schwarz
    Psychiatric Hospital, Ludwig Maximilian University Munich, Nussbaumstr 7, 80336, Munich, Germany
    Eur Arch Psychiatry Clin Neurosci 256:72-6. 2006
    ....
  54. ncbi Multicentre evaluation of a new assay for determination of carbohydrate-deficient transferrin
    Markus J Schwarz
    Psychiatrische Klinik der Ludwig Maximilian Universität, Munchen, Germany
    Alcohol Alcohol 38:270-5. 2003
    ..The analytical performance of the new Tina-quant % carbohydrate-deficient transferrin (%CDT) was assessed in a multicentre study on Roche/Hitachi analysers...